Diabetes Med Metformin Could Cut Risks for Long COVID
By Ernie Mundell HealthDay Reporter
THURSDAY, Sept. 19, 2024 -- One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID.
Long COVID can present with symptoms including chronic fatigue, brain fog and chest pain and it may last weeks or months after an initial COVID infection. It's thought that millions of Americans suffer with the illness.
As the researchers note, one study published last year found that overweight or obese COVID patients who took metformin soon after infection had a 41% reduction in their odds for Long COVID.
"Metformin has clinical benefits when used as outpatient treatment for COVID-19 and is globally available, low-cost and safe," wrote the authors of that study, which was led by Dr. Caroline Bramante, of the University of Minnesota.
The new study sought to determine if the same benefits would occur among people taking metformin for their type 2 diabetes.
A team led by Stephen Johnson, also of the University of Minnesota, compiled data on almost 76,000 Americans who were taking metformin for their type 2 diabetes.
Their rates of a diagnosis of Long COVID were compared to another group of more than 13,000 people with diabetes who were not using metformin.
Johnson's team found that folks who took metformin had an up to 21% lower odds of either developing Long COVID or dying within six months of contracting COVID-19.
How might the drug ward off COVID's worst effects?
A news release from the National Institutes of Health (NIH) said that, "scientists are not clear how metformin may prevent long COVID, but they speculate the possibility of several mechanisms that reduce inflammation, decrease viral levels and suppress the formation of disease-related proteins."
The NIH funded the research, which was published Sept. 17 in the journal Diabetes Care.
Sources
- U.S. National Institutes of Health, news release, Sept. 17, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted September 2024
Further Support and Information on COVID-19
Read this next
Insomniacs With Inflammation Prone To Depression
THURSDAY, July 17, 2025 — Insomniacs have a much higher risk for depression if they have chronic inflammation, a new sleep lab experiment says. Seniors with insomnia were...
CDC Says COVID-19 Cases Rising in 25 States
MONDAY, July 14, 2025 — COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast and West Coast. The U.S...
FDA Fully Approves Moderna’s COVID Vaccine for Some Young Kids
FRIDAY, July 11, 2025 — Moderna’s COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children with medical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.